VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
15.30
+0.10 (+0.66%)
At close: 4:00PM EDT

15.30 0.00 (0.00%)
After hours: 4:46PM EDT

Stock chart is not supported by your current browser
Previous Close15.20
Open15.55
Bid12.05 x 100
Ask16.95 x 100
Day's Range14.90 - 15.55
52 Week Range10.75 - 18.58
Volume455,267
Avg. Volume205,796
Market Cap645.71M
Beta0.50
PE Ratio (TTM)30.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.50 (3.34%)
Ex-Dividend Date2017-08-03
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals2 days ago

    One of Cincinnati’s largest public companies names new CEO

    One of the largest public companies in Greater Cincinnati has a new leader. John “Jack” Kenny was named CEO of Meridian Biosience Inc. (VIVO) effective Oct. 9, the company announced. Kenny’s appointment follows the company’s succession plan that was released earlier this year and comes after several months of searching for its next top executive.

  • Capital Cube8 days ago

    ETFs with exposure to Meridian Bioscience, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Meridian Bioscience, Inc. Here are 5 ETFs with the largest exposure to VIVO-US. Comparing the performance and risk of Meridian Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 25, 2017
    Capital Cube25 days ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 14, 2017
    Capital Cubelast month

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Meridian Bioscience, Inc. : August 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Meridian Bioscience, Inc. Here are 5 ETFs with the largest exposure to VIVO-US. Comparing the performance and risk of Meridian Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q3, 2017 By the Numbers : August 21, 2017
    Capital Cube2 months ago

    Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q3, 2017 By the Numbers : August 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Meridian Bioscience, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Meridian Bioscience, Inc. – Alere Inc., Quidel Corporation, Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and Oxford Immunotec Global PLC (ALR-US, QDEL-US, HOLX-US, BDX-US, TMO-US ... Read more (Read more...)

  • Meridian (VIVO) Initiates illumigene CMV Trial, Shares Shine
    Zacks2 months ago

    Meridian (VIVO) Initiates illumigene CMV Trial, Shares Shine

    Solid share price rally following the news suggests that the latest development is likely to buoy Meridian's (VIVO) bottom line and enhance its illumigene platform.

  • Meridian Bioscience, Inc. – Value Analysis (NASDAQ:VIVO) : August 8, 2017
    Capital Cube2 months ago

    Meridian Bioscience, Inc. – Value Analysis (NASDAQ:VIVO) : August 8, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Meridian Bioscience, Inc. a score of 75. Our analysis is based on comparing Meridian Bioscience, Inc. with the following peers – Alere Inc., Quidel Corporation, ERBA Diagnostics, Inc., Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Oxford Immunotec Global PLC and BG Medicine, Inc. (ALR-US, ... Read more (Read more...)

  • Associated Press3 months ago

    Meridian Bioscience meets 3Q profit forecasts

    The Cincinnati-based company said it had profit of 1 cent per share. Earnings, adjusted for asset impairment costs, came to 16 cents per share. The results met Wall Street expectations. The average estimate ...

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : July 27, 2017
    Capital Cube3 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : July 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Reuters3 months ago

    FDA raises concerns about Meridian's plant that makes lead tests

    The U.S. health regulator on Thursday raised concerns about Meridian Bioscience Inc's facility that manufactures lead testing devices, nearly two months after the regulator warned that the tests may underestimate lead levels in blood. The Food and Drug Administration said it had issued Meridian unit, Magellan Diagnostics, a Form 483 for its North Billerica, Massachusetts-based facility, which manufactures the devices. Magellan's devices are the only lead testing products cleared by the FDA and account for about half of all lead tests in the United States.

  • Reuters3 months ago

    FDA raises fresh concerns over Meridian's lead testing device

    The U.S. Food and Drug Administration on Thursday raised concerns about Meridian Bioscience Inc's facility that manufactures its testing device nearly two months after the regulator warned the tests underestimate lead levels in blood. The FDA issued a Form 483 to Magellan Diagnostics, which was bought by Meridian Bioscience in 2016 for $66 million, noting that the design validation does not ensure the device conforms to defined user needs. In May, the regulator warned laboratories and healthcare professionals not to use any lead testing device made by the company to test blood drawn from veins.

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : May 29, 2017
    Capital Cube5 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : May 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Top Ranked Income Stocks to Buy for May 24th
    Zacks5 months ago

    Top Ranked Income Stocks to Buy for May 24th

    Top Ranked Income Stocks to Buy for May 24th

  • Capital Cube5 months ago

    ETFs with exposure to Meridian Bioscience, Inc. : May 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Meridian Bioscience, Inc. Here are 5 ETFs with the largest exposure to VIVO-US. Comparing the performance and risk of Meridian Bioscience, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Reuters5 months ago

    UPDATE 3-U.S. health officials warn of problems with Meridian lead tests

    U.S. health officials on Wednesday warned that tests made by Meridian Bioscience Inc may underestimate lead levels in blood drawn from veins, sending the manufacturer's stock down 9 percent. The Food and Drug Administration warned laboratories and healthcare professionals not to use any lead testing device made by Magellan Diagnostics, a company acquired by Meridian in 2016 for $66 million, to test blood drawn from veins. The devices are the only lead testing products cleared by the FDA and account for about half of all lead tests in the United States.

  • Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q2, 2017 By the Numbers : May 18, 2017
    Capital Cube5 months ago

    Meridian Bioscience, Inc. :VIVO-US: Earnings Analysis: Q2, 2017 By the Numbers : May 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Meridian Bioscience, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Meridian Bioscience, Inc. – Quidel Corporation, Hologic, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and Oxford Immunotec Global PLC (QDEL-US, HOLX-US, BDX-US, TMO-US and OXFD-US) that ... Read more (Read more...)

  • Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : May 18, 2017
    Capital Cube5 months ago

    Meridian Bioscience, Inc. breached its 50 day moving average in a Bearish Manner : VIVO-US : May 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Tests for lead poisoning may be faulty, US regulators warn
    Associated Press5 months ago

    Tests for lead poisoning may be faulty, US regulators warn

    U.S. health agencies on Wednesday warned that certain blood tests for lead poisoning may give results lower than the actual level of lead.

  • Top Ranked Income Stocks to Buy for May 12th
    Zacks5 months ago

    Top Ranked Income Stocks to Buy for May 12th

    Top Ranked Income Stocks to Buy for May 12th

  • Associated Press6 months ago

    Meridian Bioscience beats 2Q profit forecasts

    On a per-share basis, the Cincinnati-based company said it had net income of 22 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...

  • Today's Bell Ringer, April 27, 2017
    CNBC Videos6 months ago

    Today's Bell Ringer, April 27, 2017

    Today's bell ringers are Ken Kozak, Meridian Bioscience at the Nasdaq, and CEO Tom Taylor, Floor & Decor Holdings, celebrating the company's IPO at the NYSE.